| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. | President of R&D, Director | Stock Option (right to buy) | 150,000 | 02 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVBP | ArriVent BioPharma, Inc. | 02 Feb 2026 | 1 | $0 | 4 | President of R&D, Director | 04 Feb 2026, 20:43 |
| AVBP | ArriVent BioPharma, Inc. | 03 Feb 2025 | 1 | $0 | 4 | President of R&D, Director | 14 Feb 2025, 16:26 |
| AVBP | ArriVent Biopharma, Inc. | 25 Jan 2024 | 0 | $0 | 3 | President of R&D, Director | 25 Jan 2024, 20:39 |